When correlating the Immunoscore with the clinical prognostic markers, such as age, gender, tumor grade, P53 status, and proliferation index (KI67), the results showed that higher AUP1's Immunoscore is associated with higher tumor grades (Fig. 2B). This evidence concerns the gene TP53 and neoplasm.